
OXiGENE Inc’s (NASDAQ:OXGN) Ovarian Cancer Medicine Gets Orphan Drug Status in Europe
Boston, MA 07/22/2013 (wallstreetpr) – OXiGENE Inc (NASDAQ:OXGN) announced that the European Medicines Agency has forwarded orphan drug standing to its ovarian cancer cure, Zybrestat. The biopharmaceutical













